Abstract:Embryonic hematopoietic stem cells (HSC) expand rapidly during development in the fetal liver. Notch1 is required for emergence of the definitive hematopoietic stem cells (HSCs) from the hemogenic endothelium, and is essential for survival and function of HSCs in the fetal liver. The identity of the ligand and the ligand-presenting cell during hematopoietic development is critical to understand how rapid expansion is attained in the fetal liver as well as to identify key niche cells that drive the robust functional potential of embryonic HSCs. In the present study, we have taken a comprehensive approach to determine the ligands and cells that initiate Notch signaling in the fetal liver. To this end, we have performed single-cell analysis for all Notch signaling proteins and many known targets in E14.5 fetal HSCs and adult bone marrow HSCs as well as fetal liver endothelial cells. We determined that Jagged1 (Jag1) is highly expressed in both endothelial cells as well as in fetal HSCs but not in adult HSCs. Our results indicate that loss of hematopoietic Jag1 severely impedes the functional ability of fetal liver HSCs to expand and differentiate during transplantation in an adult host. RNA-Sequencing analysis of fetal HSCs in Jag1-mutant embryos revealed reduced expression of Gata2, Mllt3, and Hoxa7. We determined that fetal liver HSCs, hematopoietic progenitors, myeloid cells and megakaryocytes express high levels of Jag1 protein on their surface. In support for the Jag1 niche function, activation of Notch signaling in Jag1-KO fetal HSCs by immobilized Jag1 ligand rescued gene expression and restored hematopoiesis following transplantation. Our findings indicate that Jag1 expressed on hematopoietic cells is an essential niche factor for maturation of HSCs in the fetal liver and for functional potential of fetal HSCs engrafting in the bone marrow microenvironment. Embryonic hematopoietic stem cells (HSC) expand rapidly during development in the fetal liver. Notch1 is required for emergence of the definitive hematopoietic stem cells (HSCs) from the hemogenic endothelium, and is essential for survival and function of HSCs in the fetal liver. The identity of the ligand and the ligand-presenting cell during hematopoietic development is critical to understand how rapid expansion is attained in the fetal liver as well as to identify key niche cells that drive the robust functional potential of embryonic HSCs. In the present study, we have taken a comprehensive approach to determine the ligands and cells that initiate Notch signaling in the fetal liver. To this end, we have performed single-cell analysis for all Notch signaling proteins and many known targets in E14.5 fetal HSCs and adult bone marrow HSCs as well as fetal liver endothelial cells. We determined that Jagged1 (Jag1) is highly expressed in both endothelial cells as well as in fetal HSCs but not in adult HSCs. Our results indicate that loss of hematopoietic Jag1 severely impedes the functional ability of fetal liver HSCs to expand and differentiate during transplantation in an adult host. RNA-Sequencing analysis of fetal HSCs in Jag1-mutant embryos revealed reduced expression of Gata2, Mllt3, and Hoxa7. We determined that fetal liver HSCs, hematopoietic progenitors, myeloid cells and megakaryocytes express high levels of Jag1 protein on their surface. In support for the Jag1 niche function, activation of Notch signaling in Jag1-KO fetal HSCs by immobilized Jag1 ligand rescued gene expression and restored hematopoiesis following transplantation. Our findings indicate that Jag1 expressed on hematopoietic cells is an essential niche factor for maturation of HSCs in the fetal liver and for functional potential of fetal HSCs engrafting in the bone marrow microenvironment.

Notch is the Key Factor in the Process of Fetal Liver Stem/progenitor Cells Differentiation into Hepatocytes

Notch inhibition promotes fetal liver stem/progenitor cells differentiation into hepatocytes via the inhibition of HNF-1β

Possibility of the enhanced progression of fetal liver stem/progenitor cells therapy for treating end-stage liver diseases by regulating the notch signaling pathway.

Bioinformatics Analysis to Screen Key Genes Implicated in the Differentiation of Induced Pluripotent Stem Cells to Hepatocytes

Several Important in Vitro Improvements in the Amplification, Differentiation and Tracing of Fetal Liver Stem/progenitor Cells.

Dynamic Expression Characteristics of Notch Signal in Bone Marrow-Derived Mesenchymal Stem Cells During the Process of Differentiation into Hepatocytes

Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds.

Wnt Antagonist SFRP3 Inhibits the Differentiation of Mouse Hepatic Progenitor Cells.

In vitro differentiation of embryonic stem cells into hepatocytes induced by fibroblast growth factors and bone morphological protein-4.

Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells

In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

Novel Insights on Notch signaling pathways in liver fibrosis

3158 – FUNCTIONAL POTENTIAL OF FETAL LIVER HEMATOPOIETIC STEM CELLS IS MAINTAINED BY JAGGED1 ACTIVATION OF NOTCH SINGALING

Notch-Dependent Expression of Epithelial-Mesenchymal Transition Markers in Cholangiocytes after Liver Transplantation

Distinct Roles of Dlk1 Isoforms in Bi-Potential Differentiation of Hepatic Stem Cells

Hepatic Stellate Cells Regulate Hepatic Progenitor Cells Differentiation Via The Tgf-Beta 1/Jagged1 Signaling Axis

Su1677 Blockage of HMGB1 Attenuates Con A-Induced Liver Fibrosis and Regulates the Balance of Treg/TH17 in Vivo

Protential of Directed Differentiation of Fetal Liver Stem Cells in Green Fluorescent Protein Transgenic Mice in Vivo and in Vitro

The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis

[Effects of Growth Factors and Extracellular Matrix on Proliferation and Differentiation of Fetal Liver Progenitor Cell in Vitro].

The Inhibitory Role Of Stromal Cell Mesenchyme On Human Embryonic Stem Cell Hepatocyte Differentiation Is Overcome By Wnt3a Treatment